Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_assertion wasGeneratedBy ECO_0000203 NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_assertion wasDerivedFrom befree-20150227 NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_assertion SIO_000772 10436809 NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_assertion evidence source_evidence_literature NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.
- NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_assertion description "[For biliopancreatic malignancy, following CEA as more historical and basic TM of gastrointestinal diseases, the mainstay marker is CA 19-9 as monosialo-ganglioside/glycolipid and sialyl derivative of lacto-N-fucopentaose II (sialyl-Lewis(a), hapten of human Lewis(a) bloodgroup determinant).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311961.RAfBMM_OB0RD2JxX2BYBTZ1tqnC7BMpwF21ObvLzxXIbI130_provenance.